LL-37 / working resource

Clinical conversation planner

Bring specific questions and a source record to a qualified clinician.

Start with the product-specific question

Cathelicidin and innate immunity

Antimicrobial mechanism separated from treatment claims. What should I know about cathelicidin and innate immunity?

The early randomized study enrolled 34 people and investigated topical LL37 for venous leg ulcers over a four-week treatment period.
Read the original record ↗

Open the LL-37 library ↗

Choose the questions that need an answer.

Use the LL-37 research to prepare a conversation, then let the clinician assess your individual situation. This worksheet does not determine eligibility or treatment.

What should I know about cathelicidin and innate immunity?What should I know about antimicrobial test-tube findings versus infection treatment?What should I know about wound-healing studies and their populations?Which evidence applies to the exact LL-37 formulation being considered?What alternatives address the same goal, and what evidence supports them?Which risks, interactions and uncertainties matter for this decision?What would count as a useful outcome, and when would it be reassessed?Who should I contact if I have a problem or an unresolved question?The specific goal or uncertainty I want to discuss

Your conversation agenda

Select questions above to create your agenda here.

Source URLs and product documents to bringAnswers, unresolved points and agreed follow-up

Share personal health details only through your care provider's appropriate private channel. This page does not send or save your notes.

These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.

Explore all six resources ↗